scispace - formally typeset
J

John C. Seely

Researcher at Research Triangle Park

Publications -  62
Citations -  2485

John C. Seely is an academic researcher from Research Triangle Park. The author has contributed to research in topics: Toxicity & Reproductive toxicity. The author has an hindex of 23, co-authored 62 publications receiving 2294 citations.

Papers
More filters
Journal ArticleDOI

Three-Generation Reproductive Toxicity Study of Dietary Bisphenol A in CD Sprague-Dawley Rats

TL;DR: BPA should not be considered a selective reproductive toxicant, based on the results of this study, and no evidence of nonmonotonic dose-response curves across generations for either sex is found.
Journal ArticleDOI

Two-generation reproductive toxicity study of dietary bisphenol A in CD-1 (Swiss) mice.

TL;DR: Dietary bisphenol A was evaluated in a mouse two-generation study and there were no treatment-related effects and no evidence of nonmonotonic dose-response curves for any parameter, therefore, BPA is not considered a selective reproductive or developmental toxicant in mice.
Journal ArticleDOI

Proliferative and Nonproliferative Lesions of the Rat and Mouse Urinary System

TL;DR: A widely accepted and utilized international harmonization of nomenclature for urinary tract lesions in laboratory animals will decrease confusion among regulatory and scientific research organizations in different countries and provide a common language to increase and enrich international exchanges of information among toxicologists and pathologists.
Journal ArticleDOI

Reproductive toxicity evaluation of dietary butyl benzyl phthalate (BBP) in rats

TL;DR: The offspring toxicity no observable effect level (NOEL) was 750 ppm, based on the presence of reduced AGD in F1 and F2 males at birth at 3750 ppm, but no effects on reproductive development, structures, or functions.
Journal ArticleDOI

Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity.

TL;DR: A second-generation, replication-competent adenovirus containing an improved yeast cytosine deaminase (yCD)/mutant(SR39) herpes simplex virus thymidine kinase fusion and ADP genes is developed, providing the scientific basis for evaluating the safety and efficacy of this technology in humans.